Trial Profile

Phase 1 clinical study of Lucid PSYCH

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 24 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lucid-PSYCH (Primary)
Indications Major depressive disorder
Focus Adverse reactions

Most Recent Events

22 Mar 2023 According to a FSD Pharma media release, company announced that it received the certificate of approval from The Alfred Ethics Committee in Australia to proceed with this trial.
31 May 2022 According to FSD Pharma media release, IND application of Lucid-PSYCH for Phase 1 trials is expected to be filed by the end of 2022
27 Oct 2021 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com